140 related articles for article (PubMed ID: 28129717)
41. Contraception and headache.
MacGregor EA
Headache; 2013 Feb; 53(2):247-76. PubMed ID: 23432442
[TBL] [Abstract][Full Text] [Related]
42. Drug safety evaluation of desogestrel.
Scala C; Leone Roberti Maggiore U; Remorgida V; Venturini PL; Ferrero S
Expert Opin Drug Saf; 2013 May; 12(3):433-44. PubMed ID: 23560561
[TBL] [Abstract][Full Text] [Related]
43. An evidence-based approach to hormonal contraception and headaches.
Harris M; Kaneshiro B
Contraception; 2009 Nov; 80(5):417-21. PubMed ID: 19835714
[TBL] [Abstract][Full Text] [Related]
44. Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk.
Batur P; Yao M; Bucklan J; Soni P; Suneja A; Farrell R; Mays M
Headache; 2023 Jun; 63(6):813-821. PubMed ID: 36752588
[TBL] [Abstract][Full Text] [Related]
45. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements.
Macgregor EA; Hackshaw A
J Fam Plann Reprod Health Care; 2002 Jan; 28(1):27-31. PubMed ID: 16259812
[TBL] [Abstract][Full Text] [Related]
46. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
[TBL] [Abstract][Full Text] [Related]
47. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).
Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Sandset PM; Martelletti P;
J Headache Pain; 2017 Oct; 18(1):108. PubMed ID: 29086160
[TBL] [Abstract][Full Text] [Related]
48. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
Loder EW; Buse DC; Golub JR
Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
[TBL] [Abstract][Full Text] [Related]
49. Thrombotic stroke and myocardial infarction with hormonal contraception.
Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N
N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997
[TBL] [Abstract][Full Text] [Related]
50. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
51. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Jick SS; Jick H
Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
[TBL] [Abstract][Full Text] [Related]
52. Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Priya K; Rajaram S; Goel N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():141-146. PubMed ID: 27863271
[TBL] [Abstract][Full Text] [Related]
53. Migraine associated with menstruation.
MacGregor A
Funct Neurol; 2000; 15 Suppl 3():143-53. PubMed ID: 11200785
[TBL] [Abstract][Full Text] [Related]
54. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
55. Headache and female hormones: what you need to know.
Silberstein SD
Curr Opin Neurol; 2001 Jun; 14(3):323-33. PubMed ID: 11371755
[TBL] [Abstract][Full Text] [Related]
56. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users.
Elaut E; Buysse A; De Sutter P; De Cuypere G; Gerris J; Deschepper E; T'Sjoen G
Contraception; 2012 May; 85(5):470-9. PubMed ID: 22133661
[TBL] [Abstract][Full Text] [Related]
57. The use of a large-scale surveillance system in Planned Parenthood Federation of America clinics to monitor cardiovascular events in users of combination oral contraceptives.
Burnhill MS
Int J Fertil Womens Med; 1999; 44(1):19-30. PubMed ID: 10206196
[TBL] [Abstract][Full Text] [Related]
58. Oral combined hormonal contraceptive associated with protection against allodynia in migraine in a cross-sectional study.
Vitali-Silva A; Vuolo IG; Gonzalez LH; Galvão RF; Farges SG; Bello VA; Poli-Frederico RC
Ir J Med Sci; 2023 Oct; 192(5):2203-2208. PubMed ID: 36720786
[TBL] [Abstract][Full Text] [Related]
59. Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research.
Ornello R; Canonico M; Merki-Feld GS; Kurth T; Lidegaard Ø; MacGregor EA; Lampl C; Nappi RE; Martelletti P; Sacco S
Expert Rev Neurother; 2020 Apr; 20(4):313-317. PubMed ID: 32056462
[No Abstract] [Full Text] [Related]
60. Combined hormonal contraceptives and migraine: An update on the evidence.
Calhoun AH; Batur P
Cleve Clin J Med; 2017 Aug; 84(8):631-638. PubMed ID: 28806162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
